Lpl Financial LLC Bei Gene, Ltd. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Lpl Financial LLC holds 1,899 shares of BGNE stock, worth $361,778. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,899

Previous 1,612 17.8%

Holding current value

$361,778

Previous $229,000 86.03%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$143.93 - $224.51 $41,307 - $64,434	287 Added 17.8%	1,899 $426,000
Q2 2024 Aug 07, 2024	SELL	$129.52 - $174.32 $5,698 - $7,670	-44 Reduced 2.66%	1,612 $229,000
Q1 2024 May 10, 2024	SELL	$141.8 - $181.47 $49,913 - $63,877	-352 Reduced 17.53%	1,656 $258,000
Q4 2023 Feb 14, 2024	SELL	$158.67 - $201.58 $3,966 - $5,039	-25 Reduced 1.23%	2,008 $362,000
Q3 2023 Nov 13, 2023	BUY	$179.87 - $225.13 $13,130 - $16,434	73 Added 3.72%	2,033 $365,000
Q2 2023 Jul 31, 2023	BUY	$178.3 - $266.78 $3,566 - $5,335	20 Added 1.03%	1,960 $349,000
Q1 2023 May 10, 2023	BUY	$215.53 - $274.5 $45,261 - $57,645	210 Added 12.14%	1,940 $418,000
Q4 2022 Feb 07, 2023	BUY	$125.51 - $229.3 $24,474 - $44,713	195 Added 12.7%	1,730 $380,000
Q3 2022 Nov 14, 2022	SELL	$131.8 - $202.24 $10,675 - $16,381	-81 Reduced 5.01%	1,535 $207,000
Q2 2022 Aug 12, 2022	SELL	$121.11 - $216.05 $26,886 - $47,963	-222 Reduced 12.08%	1,616 $262,000
Q1 2022 May 16, 2022	SELL	$146.52 - $269.56 $65,787 - $121,032	-449 Reduced 19.63%	1,838 $347,000
Q4 2021 Feb 14, 2022	SELL	$248.56 - $389.34 $50,209 - $78,646	-202 Reduced 8.12%	2,287 $620,000
Q3 2021 Nov 15, 2021	BUY	$249.6 - $403.14 $186,201 - $300,742	746 Added 42.8%	2,489 $904,000
Q2 2021 Aug 13, 2021	BUY	$292.75 - $367.01 $147,546 - $184,973	504 Added 40.68%	1,743 $598,000
Q1 2021 May 14, 2021	BUY	$260.64 - $382.12 $48,218 - $70,692	185 Added 17.55%	1,239 $431,000
Q4 2020 Feb 12, 2021	BUY	$221.31 - $316.61 $15,713 - $22,479	71 Added 7.22%	1,054 $272,000
Q3 2020 Nov 09, 2020	BUY	$189.18 - $286.44 $185,963 - $281,570	983 New	983 $282,000

Others Institutions Holding BGNE

# of Institutions

250

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $19.8B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Bei Gene, Ltd. Transaction History